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Continuous, high-rate production of red blood 
cells and platelets is required to sustain vertebrate 
life. The erythroid and megakaryocytic lineages 
are thought to share initial differentiation steps 
from hematopoietic stem cells (HSCs; Akashi 
et al., 2000; Pronk et al., 2007). After loss of other 
fate potentials and passage through a bipotent 
progenitor stage, the lineages segregate into dis-
tinct terminal maturation pathways, culminating 
in the production of erythrocytes and platelets.
During maturation, cells of both lineages 
execute complex lineage-specific programs. In 
erythroid cells, these include coordinated heme 
biosynthesis and globin production, as well as 
nuclear condensation and the terminal expul-
sion of the nucleus (Hattangadi et al., 2011). In 
megakaryocytic differentiation, polyploid, mul-
tilobulated nuclei are generated as a result of en-
domitosis, and a large cytoplasm is formed, which 
provides a reservoir for platelet-specific granules, 
a system of demarcation membranes, and micro-
tubules (Schulze and Shivdasani, 2005; Chang 
et al., 2007; Tijssen and Ghevaert, 2013). These 
cytoplasmic elements are ultimately consumed in 
the formation of proplatelets; thin megakaryocyte 
extensions that protrude into the intravascular 
space, where they segment and separate, releas-
ing platelets into the blood stream (Kaushansky, 
2008; Machlus and Italiano, 2013).
The erythroid and megakaryocytic lineages 
share a cadre of common transcriptional regu-
lators,  including  Gata1,  Nf-e2,  Fog1/Zfpm1, 
Scl/Tal1, and Gfi-1b, all of which are preferentially 
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The zinc finger transcriptional repressor Gfi-1b is essential for erythroid and megakaryo-
cytic development in the embryo. Its roles in the maintenance of bone marrow erythropoi-
esis and thrombopoiesis have not been defined. We investigated Gfi-1b’s adult functions 
using a loxP-flanked Gfi-1b allele in combination with a novel doxycycline-inducible Cre 
transgene that efficiently mediates recombination in the bone marrow. We reveal strict, 
lineage-intrinsic requirements for continuous adult Gfi-1b expression at two distinct 
critical stages of erythropoiesis and megakaryopoiesis. Induced disruption of Gfi-1b was 
lethal within 3 wk with severely reduced hemoglobin levels and platelet counts. The ery-
throid lineage was arrested early in bipotential progenitors, which did not give rise to 
mature erythroid cells in vitro or in vivo. Yet Gfi-1b/ progenitors had initiated the eryth-
roid program as they expressed many lineage-restricted genes, including Klf1/Eklf and  
Erythropoietin receptor. In contrast, the megakaryocytic lineage developed beyond the 
progenitor stage in Gfi-1b’s absence and was arrested at the promegakaryocyte stage, after 
nuclear polyploidization, but before cytoplasmic maturation. Genome-wide analyses revealed 
that Gfi-1b directly regulates a wide spectrum of megakaryocytic and erythroid genes, 
predominantly repressing their expression. Together our study establishes Gfi-1b as a 
master transcriptional repressor of adult erythropoiesis and thrombopoiesis.
© 2014 Foudi et al.  This article is distributed under the terms of an Attribution– 
Noncommercial–Share Alike–No Mirror Sites license for the first six months after 
the publication date (see http://www.rupress.org/terms). After six months it is   
available under a Creative Commons License (Attribution–Noncommercial–Share   
Alike 3.0 Unported license, as described at http://creativecommons.org/licenses/ 
by-nc-sa/3.0/).
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formation (Saleque et al., 2002), these findings raised the ques-
tion of whether the requirement for Gfi-1b was less strin-
gent in the adult than in the embryo. Here, we clarify these 
issues, identify strict, lineage-intrinsic requirements for Gfi-1b 
at distinct stages of adult erythropoiesis and thrombopoiesis, 
and illuminate Gfi-1b’s position in the network of lineage-
specific regulators.
RESULTS
Gfi-1b loss interrupts adult bone marrow red blood cell  
and platelet production at different stages
We generated a conditional mouse strain, in which exons 2–5 
of Gfi-1b (encoding the N-terminal portion of the protein; 
start codon to zinc finger 2) are flanked by loxP sites (floxed; 
Fig. 1 A, top). For conditional disruption, a floxed Gfi-1b al-
lele was combined with a germline-excised Gfi-1b KO allele 
(Fig. 1 A, bottom), so that single excision events achieved bi-
allelic absence of intact Gfi-1b (KO/floxed → Cre → /). 
In control mice, a floxed allele was combined with a WT allele 
(WT/floxed → Cre → +/). Excision was mediated either 
by the Mx-Cre transgene, which efficiently excises floxed alleles 
in the bone marrow upon injection of polyinosinic:poly-
cytidylic acid (pIpC; Kühn et al., 1995; Hock et al., 2004b), 
or a novel doxycycline-inducible Cre transgene (TetO-Cre; 
Fig. 2). With either system, conditional disruption of Gfi-1b 
resulted in similar hematopoietic abnormalities and was uni-
formly lethal in less than 3 wk (Fig. 3, A and B). Analysis of 
complete blood counts from moribund animals revealed pro-
found anemia with hemoglobin levels as low as 1–2 g/dl, se-
vere thrombocytopenia, and in some cases no detectable blood 
platelets (Fig. 3 B). In contrast, lymphocyte counts and gran-
ulocyte counts were not significantly changed compared with 
controls (Fig. 3 B). As blood granulocytes are short-lived, the 
latter finding is consistent with previous conclusions that Gfi-1b 
is dispensable for HSC maintenance (Hock et al., 2004a; 
Khandanpour et al., 2010).
Immunoflow cytometry revealed that differentiated ery-
throid precursors at and beyond the proerythroblast stage were 
absent in Gfi-1b/ bone marrow (Fig. 3 C). Abundant eryth-
roid progenitors were detectable in the spleen after Gfi-1b  
disruption, but genotyping of sorted splenic, erythroid cells 
(Ter119+) from Mx-Cre– and TetO-Cre–induced mice revealed 
that these exclusively harbored unexcised Gfi-1b allele (not de-
picted). These findings suggested that Cre-mediated Gfi-1b de-
letion was more efficient in the bone marrow than in the spleen, 
but terminal erythroid maturation strictly required Gfi-1b 
at either site. Immunophenotypic progenitor analysis (Pronk 
et al., 2007) of bone marrow cells demonstrated that the strict 
requirement for Gfi-1b in the erythroid lineage preceded the 
proerythroblast stage. Thus, monopotent erythroid progeni-
tors were not detectable after Gfi-1b disruption (pre–CFU-Es 
and CFU-Es; Fig. 3 D). In contrast, earlier bipotent progeni-
tors of megakaryocytes and erythrocytes (pre-MegEs; Pronk 
et al., 2007) were markedly increased in Gfi-1b/ bone mar-
row (Fig. 3 D, right, orange frames). Cytological analysis of 
sorted pre-MegEs revealed a proportion of cells with subtle 
expressed in both lineages and exert important roles in erythroid 
and/or megakaryocytic development (Kerenyi and Orkin, 
2010). In addition, some factors are expressed and function in 
just one of the lineages, specifically Klf1 (formerly Eklf), an 
essential driver of erythropoiesis (Yien and Bieker, 2013), and 
Fli-1, which promotes megakaryopoiesis and antagonizes Klf1 
(Starck et al., 2003, 2010). Gene-targeting studies in mice have 
shown that bilineage expression does not always predict promi-
nent functional roles in both lineages. Thus, severe blocks in 
erythroid development at the progenitor and erythroblast stages 
were observed after Gata1 loss (Pevny et al., 1991; Gutiérrez 
et al., 2008; Mancini et al., 2012). However, absence of Gata1 
did not abrogate megakaryopoiesis, even if it was associated 
with significantly reduced blood platelet counts and abnor-
mal megakaryocytes (Vyas et al., 1999; Gutiérrez et al., 2008). 
Conversely, Nf-e2 was largely dispensable for erythroid de-
velopment, whereas its disruption caused severe thrombocy-
topenia with abnormal, mature megakaryocytes (Shivdasani 
et al., 1995; Lecine et al., 1998). Gata1’s cofactor Fog1 is essential 
for the maintenance of both lineages. In the erythroid lineage, 
Fog1 disruption resulted in phenotypes similar to those found 
after Gata1 loss (Tsang et al., 1998; Mancini et al., 2012). How-
ever, unlike Gata1, Fog1 is required for megakaryocytic de-
velopment at a very early stage, preceding the formation of 
committed progenitors (Tsang et al., 1998; Mancini et al., 2012). 
In distinction from the above factors, Scl/Tal1, essential for em-
bryonic specification of all hematopoietic lineages (Porcher 
et al., 1996), is not strictly required for adult bone marrow 
erythropoiesis or thrombopoiesis. Its loss was associated with 
reduced blood counts and abnormal colony formation ex vivo 
(Mikkola et al., 2003), but production of mature cells was suf-
ficient to prevent severe cytopenias and morbidity (Hall et al., 
2005; McCormack et al., 2006; Chagraoui et al., 2011). Likely, 
Scl’s important adult role is partially obscured by redundancy 
with the closely related Lyl-1, which also supports erythro-
poiesis (Souroullas et al., 2009; Capron et al., 2011). Finally, 
Lmo2 and Ldb1, constituents of pentameric complexes with 
Scl and Gata1 (Wadman et al., 1997; El Omari et al., 2013), are 
indispensable for erythropoiesis and thrombopoiesis (Warren 
et al., 1994; Li et al., 2010, 2013).
In this study, we address the role of Gfi-1b in adult eryth-
ropoiesis and thrombopoiesis. An essential role for Gfi-1b in 
megakaryocytic and erythroid development has been defined 
in the embryo (Saleque et al., 2002). Studies in murine and 
human erythroid and megakaryocytic cell culture systems sug-
gested that Gfi-1b’s role persisted in adult cells, but a require-
ment for Gfi-1b expression has not been demonstrated in the 
bone marrow (Osawa et al., 2002; Garçon et al., 2005; Saleque 
et al., 2007; Randrianarison-Huetz et al., 2010). In addition, 
the precise stage of Gfi-1b’s role within the two lineages and 
its relation to other transcription factor requirements have not 
been defined. Finally, it was recently reported that a conditional 
KO of Gfi-1b in adult HSCs was not associated with severe, 
early erythroid, or megakaryocytic phenotypes (Khandanpour 
et al., 2010). As Gfi-1b disruption in embryos resulted in lethal 
anemia and defective erythroid and megakaryocytic colony JEM Vol. 211, No. 5 
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Figure 1.  Generation of a conditional Gfi-1b allele in ES cells and mice. (A) A scheme of the Gfi-1b protein domains illustrating the targeted 
regions is shown above the restriction maps. LoxP-flanked regions include coding exons for the entire N-terminal protein (ATG-ZF2). The restriction maps 
show the genomic Gfi-1b locus (top; coding exons in red and noncoding exons in black), the targeting vector (second), the targeted locus after Flp-mediated 
deletion of NeoR (third), and the excised locus (fourth). The bottom shows a constitutively deleted Gfi-1b allele (KO) generated by Cre-mediated deletion 
without excision of the NeoR gene. (B–F) Southern blot analyses of Gfi-1b alleles. (B) Documentation of correct targeting at 5 (digest: BamHI; expected 
sizes: WT = 12.8 kb, targeted allele = 8.3 kb; probe: 5 as shown in A). (C) Documentation of correct targeting at 3 (digest: BamHI/EcoRV; expected sizes: 
WT = 3 kb, targeted allele = 2 kb; probe: 3 as shown in A). (D) Documentation of deletion of neoR cassette using Flpe (digest: BamHI; expected sizes:  
WT = 12.8 kb, floxed-neo+ = 8.3 kb, floxed-neo = 6.1 kb; probe: 5 as shown in A). (E) Documentation of Cre-mediated excision of exons 2–5 in ES cells to 
generate the constitutive KO allele (A, bottom; digest: BamHI; expected sizes: WT = 12.8 kb; floxed-neo+ = 8.3 kb; KO = 10.5 kb; probe: 5 as shown in A). 
(F) Southern blot analysis for genotyping and determination of excision status (digest: BamHI; expected sizes: WT = 12.8 kb, floxed = 6.1 kb, excised = 6.8 kb, 
KO = 10.5 kb; probe: 5 as shown in A). (G–I) Gfi-1b genotyping and excision PCR strategies. (G) Scheme of Gfi-1b PCR strategy. (H) Representative geno-
typing PCR using four primers as shown in G from tail-tip DNA samples (expected bands: WT, 200 bp; floxed, 350 bp; KO, 900 bp). (I) Representative exci-
sion PCR using three primers as shown in A from bone marrow cells before () and after (+) pIpC treatment (expected bands: WT, 200 bp; floxed, 350 bp; 
excised, 300 bp; KO, no band).912 Gfi-1b in adult red cell and platelet generation | Foudi et al.
approximately fivefold in Gfi-1b/ bone marrow (Gfi-1b+/ 
0.4 ± 0.1% and Gfi-1b/ 1.89 ± 0.4%, n = 3/group, P < 
0.005). As endomitosis is completed before the promegakaryo-
cyte stage, in megakaryoblasts (see also Fig. 9; Chang et al., 
2007), these data suggested that Gfi-1b was dispensable for poly-
ploidization. Confirming this conclusion, analysis of DNA con-
tent of Gfi-1b/ versus control bone marrow cells revealed 
no differences in the frequency or distribution of hyperdip-
loid cells (Fig. 3 J).
Together, Gfi-1b loss affects adult megakaryocytic and 
erythroid development at different stages. In the absence of 
Gfi-1b, erythroid development is ablated early in progenitors, 
whereas megakaryocytic maturation proceeds beyond the pro-
genitor stage to the formation of polyploid promegakaryocytes 
that fail to mature and produce platelets.
Strict requirement for Gfi-1b in erythroid  
and megakaryocytic colony differentiation
To assess whether Gfi-1b is required for terminal differentia-
tion within erythroid and megakaryocytic lineage cells, we first 
analyzed colony formation from Gfi-1b/ or control lineage-
committed progenitors in the presence of a cytokine combi-
nation that allows for differentiation into all myeloid lineages. 
As expected (Pronk et al., 2007), sorted control MkPs (Fig. 3 D, 
yellow frame) predominantly gave rise to colonies contain-
ing only megakaryocytes (CFU-Mk) and very few (<10%) 
colonies containing both erythroid cells and megakaryo-
cytes (CFU-EMk; Fig. 4 A, left). This was judged by colony 
morphology (Fig. 4 B, left) as well as cellular morphology and 
AchE activity of cytospin preparations (Fig. 4 C, left). In con-
trast, Gfi-1b/ MkPs did not give rise to megakaryocytes or 
terminal erythroid cells. Instead, they generated atypical, very 
erythroid features (scant cytoplasm, round nucleus, and denser 
chromatin) in the presence or absence of Gfi-1b (Fig. 3 E, left). 
Hence, Gfi-1b was not required for some aspects of morpho-
logical erythroid maturation at the pre-MegE stage, but in its 
absence, development did not proceed to the monopotent pro-
genitor stage and beyond.
Immunophenotypic analysis of early megakaryocytic de-
velopment demonstrated that Gfi-1b/ bone marrow cells 
harbored markedly increased numbers of monopotent mega-
karyocytic progenitors (MkPs; Fig. 3 D, left, yellow frames) 
with normal, characteristic morphology (Fig. 3 E, right). Fur-
ther immunophenotypic analysis suggested that develop-
ment proceeded beyond the progenitor stage with a markedly 
increased number of cells bearing megakaryocyte markers 
(CD41+/CD42b+; Fig. 3 F). However, normal megakaryo-
cytes were not detected in Gfi-1b/ bone marrow sections 
stained with hematoxylin and eosin (H&E; Fig. 3 G). Histo-
chemical analysis of bone marrow cell cytospin preparations 
for acetylcholinesterase (AchE) activity, a marker of late mega-
karyocyte maturation (Fig. 3 H, left), and morphological ana-
lysis after May-Grünwald Giemsa (MGG) staining (Fig. 3 H, 
right) confirmed the absence of mature megakaryocytes. How-
ever, the cytospin preparations revealed cells with multilob-
ulated, segmented nuclei (Fig. 3 H, right, bottom, arrows). 
These were highly enriched after sorting CD41+/CD42b+ cells 
(Fig. 3 I). They were 15–25 µm in diameter and displayed scant, 
basophilic cytoplasm with a high nucleus/cytoplasm ratio. Faint 
azurophilic granules were perceptible (not depicted). The mor-
phology of the Gfi-1b/ multilobulated cells closely resem-
bles that of normal promegakaryocytes (Long and Williams, 
1981), although they were larger (Fig. 3 I). The frequency 
of cells with promegakaryocyte morphology was increased 
Figure 2.  Generation of mice that permit doxycycline-
inducible expression of Cre recombinase (TetO-Cre). 
(A) Alleles for doxycycline-inducible Cre expression. (top) The 
M2 reverse tetracycline transactivator (M2-rtTA) is constitu-
tively transcribed off the ROSA26 promoter as described in 
Beard et al. (2006). (middle) Flp-recombinase–mediated site-
specific integration was used as described previously (Beard 
et al., 2006) to insert the Cre cDNA in the 3 UTR region of the 
Collagen (Col) 1A1 locus under the control of a tetracycline-
dependent minimal CMV promoter. (bottom) Upon doxycy-
cline treatment (yellow dots), the M2 reverse tetracycline 
transactivator (red semicircles) binds to the CMV promoter 
and Cre expression is turned on. pA, poly A; TetOP, tetracy-
cline operator elements fused to CMV minimal promoter.  
(B) Southern blot analysis confirming integration of the Cre 
transgene in the Col1A1 locus (left) and M2-rtTA Flp-in the 
ROSA26 locus (right). ES cells double heterozygous for  
M2-rtTA and TetOP-Cre were used to generate chimeric ani-
mals and germline offspring (not depicted). (C) Representa-
tive products after three-primer competitive genotyping  
PCR for Col1A1 and ROSA26 loci from tail-tip genomic DNA. 
Col1A1 expected bands: Flp-in, 550 bp; WT, 330 bp. ROSA26 
expected bands: Flp-in, 300 bp; WT, 550 bp. het, heterozy-
gous; homo, homozygous.JEM Vol. 211, No. 5 
Article
913
Figure 3.  Induced disruption of Gfi-1b in the bone marrow. (A) Kaplan–Meyer survival analysis after conditional Gfi-1b disruption using Mx-Cre 
(pIpC; +/ n = 15; / n = 13) or TetO-Cre (doxycycline; +/ n = 4; / n = 4). (B) Automated, complete blood counts after induction of Mx-Cre  
(top; +/ n = 5; / n = 6) or TetO-Cre (middle; days 12–19, +/ n = 4; / n = 4). Bottom panels show representative platelet volume histograms. 
(C) Flow cytometric analysis of bone marrow erythroid maturation (day 13). One representative of five independent experiments is shown. (D) Flow  914 Gfi-1b in adult red cell and platelet generation | Foudi et al.
confirmed that complete excision was achieved (Fig. 5 C). 
The excised allele was maintained in all control populations 
bearing a combination of alleles that produced a heterozygous 
state (Cre → +/). After biallelic Gfi-1b loss (Cre → /), 
the excised Gfi-1b allele also remained abundant in Gr-1+/
Mac-1+ granulocytes, pre-MegEs, and MkPs (Fig. 5 C, second, 
fourth, and sixth lanes), demonstrating that these populations 
were maintained in Gfi-1b’s absence. However, the excised 
allele could not be detected in erythroblasts (Ter119+CD71+), 
and this population only contained cells derived from the WT 
competitor marrow (Fig. 5 C, seventh and eighth lanes). These 
findings suggested striking selection against Gfi-1b loss after, 
but not at or preceding the pre-MegE stage of erythroid dif-
ferentiation. Analysis of CD41+CD42b+ megakaryocytic cells 
also revealed moderate selection for WT Gfi-1b compared 
with MkPs, but the Gfi-1b/ allele predominated (Fig. 5 C, 
5th, 6th, 9th, and 10th lanes). Analysis of donor or recipient 
origin with CD45 allelic variants confirmed that MkPs and 
pre-MegEs were predominantly derived from the condi-
tional donor marrow after Gfi-1b loss, whereas CFU-Es were 
almost exclusively derived from the competitor marrow after 
biallelic Gfi-1b disruption (Fig. 5 D). We used a combination 
of high-resolution microscopy and flow cytometry (Amnis 
ImageStream MkII system) to study the impact of Gfi-1b on 
terminal megakaryocytic differentiation in transplant recipi-
ents. With this technology, we collected 93 (Gfi-1b+/ trans-
plant recipients) and 195 (Gfi-1b/ recipients) images of 
CD41+CD42b+ late megakaryocyte lineage cells and assessed 
their overall size, nuclear morphology, and CD45.2 expres-
sion (Fig. 5, E and F). As expected, the CD45.2-negative cells 
derived from the competitor marrow included very large, 
mature megakaryocytes with convoluted nuclei. This was un-
changed in CD45.2-positive conditional control cells bear-
ing heterozygous Gfi-1b (Fig. 5, E and F, top). However, after 
biallelic Gfi-1b loss, CD45.2-positive CD41+CD42b+ cells 
were invariably small despite the presence of convoluted nu-
clei (Fig. 5, E and F, bottom). Hence, the early erythroid pro-
genitor arrest and the terminal megakaryocytic differentiation 
defect after Gfi-1b loss are reproducible in a WT bone mar-
row microenvironment.
large colonies that contained immature cells lacking AchE 
activity (Fig. 4, A–C, right). Thus, Gfi-1b is intrinsically re-
quired for megakaryocyte maturation from committed pro-
genitors in vitro.
Because monopotent erythroid progenitors were absent 
after Gfi-1b loss (Fig. 3 D), we tested erythroid differentiation 
with colony assays from sorted pre-MegEs, a bipotent progeni-
tor population with predominant erythroid output (Fig. 3 D, 
orange frame). Consistent with previous findings (Pronk et al., 
2007), control pre-MegEs gave rise to CFU-Mks as well as 
bilineage CFU-EMk and a majority of erythroid colonies 
(BFU-E; Fig. 4, D and E). Cytospin preparations of the colonies 
confirmed robust terminal erythroid differentiation, includ-
ing the presence of enucleated red cells and abundant hemo-
globin  production  demonstrated  by  benzidine  reactivity   
(Fig. 4 F, left). In contrast, Gfi-1b/ pre-MegEs only gave 
rise to atypical large colonies (Fig. 4, D and E, right). In cyto-
spin preparations, a larger proportion of cells bore some resem-
blance to early erythroid cells compared with cells in colonies 
from MkPs, but hallmarks of terminal erythroid differentiation, 
such as nuclear condensation or maturation of the cytoplasm, 
were not appreciated (Fig. 4 F, top right). Consistent with 
these observations, no benzidine-reactive cells were detected 
(Fig. 4 F, bottom right). Hence, Gfi-1b is also intrinsically re-
quired for erythroid maturation from committed progeni-
tors in vitro.
Gfi-1b disruption results in arrested erythroid  
and megakaryocytic differentiation in a WT  
bone marrow microenvironment
To investigate the requirement for Gfi-1b in the presence of 
a WT microenvironment and without anemia or thrombocy-
topenia, we transplanted unexcised Gfi-1b conditional bone 
marrow cells (KO/floxed or WT/floxed; CD45.2) into lethally 
irradiated recipients (CD45.1) together with WT support bone 
marrow (CD45.1; Fig. 5 A). After engraftment and recovery 
of hematopoiesis, we disrupted Gfi-1b by doxycycline adminis-
tration. As expected in the presence of WT competitor marrow, 
Gfi-1b disruption did not result in cytopenias (Fig. 5 B). Geno-
type analysis of DNA from sorted bone marrow populations 
cytometric analysis of bone marrow progenitors (day 13; Pronk et al., 2007); monopotent erythroid progenitors (pre–CFU-E, CFU-E) were undetectable, 
but bipotent pre-MegEs and monopotent MkPs were increased after Gfi-1b loss. Numbers are frequencies of total bone marrow cells (representative of 
four independent experiments). (E) Cytospin preparations of flow-sorted pre-MegEs (left) and MkPs (right) stained with MGG. The morphology of both 
populations (including binucleated MkPs, arrows) was preserved after Gfi-1b disruption. (F) Flow cytometric analysis of bone marrow megakaryocyte mat-
uration (day 15). CD41+CD42b+ megakaryocytic cells were increased 15-fold in Gfi-1b/ bone marrow. Numbers are frequencies of total bone marrow 
cells (representative of four independent experiments). (G) H&E stain of whole mount bone marrows (day 15) showing the absence of mature megakaryo-
cytes after Gfi-1b loss (/, right). (H) Histochemical analysis (left) and MGG stain (right) of total bone marrow cytospin preparations (day 15). After  
Gfi-1b disruption, no mature megakaryocytes were detected with AchE or MGG stains, but immature multilobulated megakaryocytic cells were abundant 
(arrows). (I) Cytospin preparations of flow-sorted Gfi-1b+/ (top) and Gfi-1b/ (bottom three rows) CD41+CD42b+ megakaryocytic cells (MGG) showing 
high nuclear/cytoplasm ratio, basophilic cytoplasm, faint azurophilic granules, and multilobulated nuclei. Bars: (E, H [right], and I) 10 µm; (G) 50 µm;  
(H, left) 100 µm. (J) Flow cytometric analysis of bone marrow cell ploidy (day 15). Combined lymphoid plus granulocytic scatter gates were used as inter-
nal diploid control (gray histograms), and scatter high gates were used to enrich for megakaryocytic cells (blue histograms). The distribution of cells with 
high ploidy was preserved after Gfi-1b disruption. Table shows mean ± SD of ploidy data from two independent experiments. Significance was deter-
mined with two-tailed Student’s t test: ***, P < 0.001. Error bars denote SDs.
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two hybrids on colony formation from Gfi-1b/ pre-MegEs 
(Fig. 6, B and C). Although progenitors infected with a control 
vector expressing GFP alone did not give rise to erythroid col-
onies or megakaryocyte-containing colonies, such colonies did 
form after infection with Gfi-1b or Gfi-1, as well as mutant-
expressing vectors. The presence of erythroid cells and mega-
karyocytes was confirmed in MGG-stained cytospin colony 
preparations (Fig. 6 D, left), as well as by demonstrating benzi-
dine reactivity (Fig. 6 D, middle) and AchE reactivity (Fig. 6 D, 
right). These data suggest that Gfi-1 and Gfi-1b exhibit a simi-
lar capacity to rescue erythroid differentiation and early mega-
karyocyte differentiation from Gfi-1b/ pre-MegEs.
To assess terminal megakaryocyte maturation, we analyzed 
proplatelet formation from Gfi-1b/ MkPs in culture with 
stem cell factor and thrombopoietin on fibronectin-coated 
dishes. (Fig. 6, E–H). After infection with a GFP control vec-
tor alone, Gfi-1b/ MkPs did not increase in size, become 
adherent, or form proplatelets (Fig. 6, F [top] and G). In con-
trast, expression of Gfi-1b and Gfi-1 was associated with cell 
adhesion and size increase, noticeable between days 2 and 5 
(Fig. 6 F, left, second and third panel from top), extrusion of 
proplatelet processes, and even release of some platelets (approx-
imately days 7–8; Fig. 6 F, right, second and third panel from 
top). However, the rescue efficiency measured by the num-
ber of megakaryocyte-forming proplatelets was significantly 
reduced with Gfi-1 compared with Gfi-1b in three indepen-
dent experiments (Fig. 6 G).
Forced Gfi-1b or Gfi-1 expression similarly rescues  
erythroid and megakaryocytic colony formation from  
Gfi-1b/ progenitors, but Gfi-1b more efficiently  
promotes proplatelet formation
To investigate whether Gfi-1, Gfi-1b’s closely related homo-
logue, could replace it in erythroid and megakaryocytic dif-
ferentiation, we studied the impact of Gfi-1 and Gfi-1b gene 
transfer into Gfi-1b/ progenitors ex vivo (Fig. 6). In most 
differentiated hematopoietic cells, Gfi-1b and Gfi-1 display 
mutually exclusive expression patterns (Hock and Orkin, 2006). 
Gfi-1b has been shown to rescue significant aspects of the phe-
notype that follows Gfi-1 loss in myeloid cells but not the inner 
ear defects in Gfi-1/ mice (Fiolka et al., 2006). It has not 
been reported whether Gfi-1 can functionally replace Gfi-1b 
in any setting. As expected from Gfi-1b’s preferential ex-
pression in erythroid and megakaryocytic cells (Saleque et al., 
2002), WT pre-MegEs and MkPs robustly expressed Gfi-1b 
(Fig. 6 A, left, black bars) but not Gfi-1 (Fig. 6 A, right, black 
bars). After Gfi-1b disruption, Gfi-1b expression was abolished 
in both populations (Fig. 6 A, left, red bars) and the expression 
of Gfi-1, a direct target of Gfi-1b (Doan et al., 2004; Vassen 
et al., 2005), was increased (Fig. 6 A, right, red bars). This sug-
gested that Gfi-1 either lacked the potential to promote termi-
nal differentiation of Gfi-1b/ progenitors or was expressed 
at insufficient levels.
We examined the impact of lentiviral vector–mediated 
gene transfer of C-terminally FLAG-tagged Gfi-1b, Gfi-1, and 
Figure 4.  Megakaryocytic and erythroid 
lineage–intrinsic requirements for Gfi-1b 
in vitro. (A–C) Colony formation from sorted 
MkPs (days 15–19 after Cre induction; SCF,  
IL-3, IL-11, GM-CSF, Epo, and Tpo). (A) Distribu-
tion of colonies with the indicated morpholo-
gies by phase-contrast microscopy (BFU-E, 
erythroid; CFU-Mk, megakaryocyte; CFU-EMk, 
erythroid/megakaryocyte; atypical; based on 
>300 colonies per genotype; three indepen-
dent experiments scored days 7–10).  
(B) Microscopic morphologies of typical  
CFU-Mks and large atypical colonies from 
Gfi-1b/ MkPs. (C) Cytospin preparations of 
pooled colonies stained with MGG (top) and 
AchE (bottom; representative results of three 
independent experiments). Gfi-1b/ MkPs 
failed to produce typical megakaryocyte colo-
nies but gave rise to large atypical colonies 
that did not contain mature megakaryocytes. 
(D–F) Colony formation from sorted bipotent 
megakaryocyte/erythrocyte progenitors (pre-
MegEs; conditions as in A–C). (D) Distribution 
of colony types (as detailed in A, >300 colonies 
per genotype, three experiments). (E) Mor-
phologies of typical BFU-Es, CFU-Mks, and 
CFU-EMks and large, atypical colonies from 
Gfi1b/ pre-MegEs. (F) Cytospin preparations 
of pooled colonies stained with MGG (top) or 
benzidine (bottom; representative results of three independent experiments). The large atypical colonies from Gfi-1b/ pre-MegEs did not contain mature 
erythroid cells (top) or benzidine-reactive (hemoglobin producing) cells (bottom). Bars: (B and E) 1 mm; (C and F, top) 10 µm; (C and F, bottom) 100 µm.916 Gfi-1b in adult red cell and platelet generation | Foudi et al.
Figure 5.  The megakaryocytic and erythroid defects after loss of Gfi-1b are blood cell autonomous in vivo. (A) Scheme of the experiment. 
(B) Automated, complete blood counts after 4 wk of doxycycline treatment in Gfi-1b+/ (n = 5) and Gfi-1b/ (n = 6) posttransplant recipients. Error 
bars represent SD. (C) Analysis of Gfi-1b gene status by PCR in sorted bone marrow populations in posttransplant recipients. Genomic DNA of sorted 
Gr1+Mac1+ neutrophils, pre-MegEs, MkPs, CD71+Ter119+ erythroblasts, CD41+CD42+ megakaryocytic cells was analyzed by competitive PCR 7 wk after JEM Vol. 211, No. 5 
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The mRNA expression levels of the erythropoietin receptor 
(approximately twofold), Klf1 (approximately twofold), and 
the erythroid membrane-associated protein (Ermap; fourfold) 
were significantly increased after Gfi-1b loss. Therefore, de-
spite the absent potential of Gfi-1b/ pre-MegEs to give rise 
to mature erythroid cells, their erythroid molecular program 
was not extinguished. Accordingly, the expression of six eryth-
roid regulators, Klf1, Gata1, Fog1, Tal1/Scl, Lmo2, and Ldb1, 
was either unchanged or increased in the absence of Gfi-1b. 
Gata2 expression was significantly reduced in pre-MegEs, in 
agreement with the prediction of a proposed regulatory triad 
between Gfi-1b, Gfi-1, and Gata2 (Moignard et al., 2013). 
However, in Gfi-1b/ MkPs, Gata2 expression was altered in 
the opposite direction (Fig. 7 C). Regardless, lentiviral expres-
sion of Gata2 failed to rescue erythroid differentiation from 
Gfi-1b/ pre-MegEs (not depicted). Together, the erythroid 
maturation arrest that follows Gfi-1b loss is unlikely to be the 
result of expression loss of a previously identified lineage-
restricted transcriptional regulator.
Gfi1b functions as a master transcriptional repressor  
of the erythroid and megakaryocytic lineages
To assess Gfi-1b’s genome-wide impact on gene expression, 
we compared mRNA profiles in control and Gfi-1b/ pro-
genitors with microarrays (Fig. 8 A and Tables S1 and S2). 
A threshold of a 1.5-fold expression change after Gfi-1b disrup-
tion defined 3,210 differentially expressed genes in pre-MegEs 
and 2,185 in MkPs, about half up- and down-regulated in 
either population. To gauge Gfi-1b’s impact at genes it occu-
pies, we used a published dataset of genomic sites that bind 
Gfi-1b in the murine hematopoietic progenitor cell line HPC-7 
(Wilson et al., 2010); 4,812 genes with peaks between 10 kb 
from the transcriptional start site and 1 kb after the gene end 
were defined as bound (Fig. 8 A and Table S3). Among di-
rect Gfi-1b targets, 54.3% (pre-MegEs; Fig. 8 A, left) and 
56.3% (MkPs, Fig. 8 A, right) were up-regulated after Gfi-1b 
loss. Gene set enrichment analysis (GSEA) showed that the 
increase of up-regulated Gfi-1b targets in Gfi-1b/ pre-
MegEs and Gfi-1b/ MkPs was highly statistically signifi-
cant (Fig. 8 B). Therefore, as expected (Zweidler-Mckay et al., 
1996; Tong et al., 1998; Saleque et al., 2007), the predom-
inant impact of the local presence of Gfi-1b is repression 
of transcription.
Finally, we studied two DNA-binding domain swap mutants. 
These  did  not  exhibit  differences  in  rescuing  erythroid  and 
megakaryocytic colonies from pre-MegEs (Fig. 6 D). Likewise, 
the first hybrid, in which the zinc finger domain of Gfi-1b 
was replaced by the zinc fingers of Gfi-1 (Fig. 6 B, third row), 
was as efficient as Gfi-1b in promoting proplatelet formation 
from MkPs (Fig. 6, F and G). However, the second hybrid, in 
which the N-terminal portion of Gfi-1b was replaced by the 
N-terminal portion of Gfi-1 (Fig. 6 B, bottom), was significantly 
less efficient than Gfi-1b and was indistinguishable from Gfi-1   
in promoting proplatelet formation (Fig. 6, F and G). The dif-
ferences in rescue efficiency were not a result of reduced pro-
tein expression (Fig. 6 H). Thus, the N-terminal portion of 
Gfi-1b confers a higher efficiency in promoting proplatelet for-
mation, whereas the zinc finger domains of both factors rescue 
terminal megakaryocyte maturation with equivalent efficiency.
Abnormal but partially preserved erythroid  
and megakaryocytic lineage gene expression  
in Gfi-1b/ progenitors
To shed light on the molecular impact of Gfi-1b loss, we first 
analyzed the expression of erythroid and megakaryocytic lin-
eage candidate genes by real-time RT-PCR of mRNA from 
sorted MkPs and pre-MegEs. In accordance with the known 
lineage biases of MkPs and pre-MegEs (Fig. 4, A and D; Pronk 
et al., 2007), MkPs expressed megakaryocytic lineage–specific 
genes at higher levels than pre-MegEs (Fig. 7 A), and pre-
MegEs expressed erythroid lineage–specific genes at higher 
levels than MkPs (Fig. 7 B).
After Gfi-1b loss in MkPs, the expression levels of mega-
karyocyte lineage genes remained higher than in pre-MegEs, 
but some were significantly altered. Specifically, the mRNA 
levels of Von Willebrand factor (1.5-fold) and Gp5 (2.5-fold) 
were decreased in Gfi-1b’s absence, whereas the levels of Fli1 
were unchanged, and the levels of the thrombopoietin receptor 
mRNA (2.2-fold) were markedly increased. Thus, Gfi-1b/ 
MkPs did not lose their molecular megakaryocytic identity. 
Consistent with this conclusion, Gfi-1b/ MkPs expressed 
normal or increased levels of 14 transcriptional regulators that 
have been implicated in the maintenance of normal platelet 
counts (Fig. 7 C).
In Gfi-1b/ pre-MegEs, erythroid lineage–specific genes 
remained expressed at higher levels than in MkPs (Fig. 7 B). 
doxycycline treatment (19 wk after transplant; fl, floxed; ex, excised; see Fig. 1 [G and I]). All populations predominantly contained Gfi-1b/ cells, 
except for erythroblasts, which exclusively contained WT cells from competitor marrow (representative of two independent experiments). (D) Flow 
cytometric analysis of bone marrow progenitors 7 wk after doxycycline treatment in Gfi-1b+/ (top) and Gfi-1b/ (bottom) posttransplant recipi-
ents. CFU-E progenitors were almost all derived from competitor cells (red frame and histogram) in Gfi-1b/ posttransplant mouse compared with 
Gfi-1b+/ controls. (E and F) Combination of quantitative imaging and flow cytometric analysis of CD41+CD42+ megakaryocytes in Gfi-1b+/ and  
Gfi-1b/ posttransplant recipients, 7 wk after doxycycline treatment. Bone marrow cells were stained with CD45.2 FITC (green pseudocolor), CD42 PE 
(yellow pseudocolor), CD41 Pacific Blue (purple pseudocolor), and DRAQ5 (DNA; red pseudocolor) and analyzed using Amnis ImageStream MkII. (E) Repre-
sentative images of competitor cell–derived (comp) CD45.2-negative and conditional cell–derived (cond) CD45.2-positive CD41+CD42+ megakaryo-
cytes in Gfi1b+/ (top) and Gfi1b/ (bottom) posttransplant recipients. Note that Gfi1b/ megakaryocytes are dramatically smaller than their WT 
counterparts. Bars, 10 µm. (F) Quantification of size of competitor cell–derived and conditional cell–derived CD41+CD42+ megakaryocytes in Gfi1b+/ 
(top) and Gfi1b/ (middle) posttransplant recipients. Table shows mean ± SD of CD41 and CD42 area scales for a total of 93 and 195 CD41+CD42+ 
megakaryocytes analyzed from Gfi1b+/ and Gfi1b/ posttransplant recipients, respectively.
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Figure 6.  Rescue of erythroid and megakaryocytic colony formation and proplatelet formation from Gfi-1b/ progenitors ex vivo. (A) Gfi-1b 
(left) and Gfi-1 (right) mRNA expression analysis in Gfi-1b+/+ and Gfi-1b/ pre-MegE and MkP bone marrow progenitors. mRNA expression relative 
to -actin expression is shown as mean ± SD of three independent biological replicates (***, P < 0.001; **, P < 0.005; *, P < 0.05; two-tailed Student’s 
t test). (B) Scheme of Gfi-1b/Gfi-1 hybrids. In the Gfi-1bN1C mutant (third row), the N terminus of Gfi-1b was fused to the C terminus of Gfi-1. In the JEM Vol. 211, No. 5 
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partially preserved as they retained morphological and molecu-
lar traits of the erythroid and megakaryocytic lineages. The 
requirement for Gfi-1b expression was evident at earlier stages 
in erythroid lineage than in the megakaryocytic lineage. Al-
though Gfi-1b/ progenitors initiated erythroid differentia-
tion and expressed many erythroid genes, they did not progress 
to the fully committed, monopotent erythroid progenitor stage. 
In contrast, megakaryocytic differentiation progressed beyond 
the progenitor stage in the absence of Gfi-1b, arresting only 
after nuclear polyploidization, before cytoplasmic maturation. 
These Gfi-1b/ phenotypes were reproduced in WT trans-
plant recipients, in the presence of normal bone marrow and 
in the absence of anemia and thrombocytopenia.
Our results contradict some findings of another study   
that examined the consequences of adult Gfi-1b disruption 
(Khandanpour et al., 2010). These authors reported only moder-
ate anemia without changes in the types of progenitor colonies 
generated from the bone marrow, including erythrocyte- and 
megakaryocyte-containing colonies. We were able to repro-
duce those findings using less efficient regimens for Gfi-1b 
disruption. A small minority of unexcised cells was sufficient 
to selectively expand and exclusively maintain late erythropoi-
esis and megakaryopoiesis (not depicted). Consistent with this, 
our transplant experiments demonstrate that strong selection 
against Gfi-1b loss occurs only late, after the pre-MegE and 
MkP stages (Fig. 5, C and D). Khandanpour et al. (2010) only 
reported the excision status of HSCs, and it remained un-
resolved whether late erythroid and megakaryocytic cells in-
deed lacked Gfi-1b. Notably, we observed comparably severe 
anemia and thrombocytopenia after Cre-mediated recombi-
nation with our doxycycline-inducible TetO-Cre and with 
Mx-Cre. Thus, the more severe phenotype associated with 
complete excision was not the result of increased interferon-
associated effects (Essers et al., 2009). We conclude that the 
erythroid and megakaryocytic phenotypes that follow adult 
Gfi-1b disruption are as severe as those demonstrated in Gfi-1b 
KO embryos (Saleque et al., 2002).
Unique role for Gfi-1b in megakaryocytic development
Gfi-1b’s role in thrombopoiesis is unique. Similar to our 
findings, severe thrombocytopenia follows loss of Nf-e2 
(Shivdasani et al., 1995), Fog1 (Tsang et al., 1998), and Ldb1 
To more specifically probe Gfi-1b’s impact on erythroid 
and megakaryocytic gene programs, we used established gene 
panels (Chen et al., 2007; Li et al., 2013). 29% (155/533) of 
the erythroid genes and 55.3% (31/57) of the megakaryocytic 
genes were bound by Gfi-1b (Table S3). Gfi-1b loss resulted 
in significant enrichment of up-regulated direct erythroid 
target genes in pre-MegEs (Fig. 8 C, left) and up-regulated 
megakaryocytic direct targets genes in MkPs (Fig. 8 C, right). 
Gfi-1b loss also altered the expression of many important eryth-
roid and megakaryocytic genes that were not bound (Fig. 8 D 
and Tables S1 and S2).
Finally, we examined the impact of Gfi-1b loss on known 
targets of other erythroid lineage transcription factors. Re-
cently, genome-wide studies have defined gene sets regulated 
by Gata1 (Yu et al., 2009), Klf1 (Tallack et al., 2012), and Ldb1 
(Li et al., 2013). Superimposing these gene sets on the defined 
erythroid gene panel showed that all three factors regulate a 
large fraction of erythroid genes and predominantly increase 
their expression (Fig. 8 E and Table S3). Gfi-1b also regulates 
a sizable fraction of the panel genes, but it stands out in that it 
represses more than two thirds of its erythroid targets (Fig. 8 E). 
Notably, a high proportion of the targets of Gata1 (44.8%), 
Ldb1 (45.8%), and Klf1 (29.7%) were occupied by Gfi-1b 
(Table S3; Wilson et al., 2010). After Gfi-1b loss in the eryth-
roid lineage (pre-MegEs), the Gfi-1b–bound target genes of 
all three factors were significantly up-regulated (Fig. 8 F). To-
gether, our genomic analysis establishes Gfi-1b as a master 
transcriptional repressor that regulates a large number of eryth-
roid and megakaryocytic genes in combination with other 
prominent regulators of these lineages. Its continuous pres-
ence is required to restrain the activity of a wide spectrum of 
genes during adult erythropoiesis and thrombopoiesis.
DISCUSSION
Gfi-1b in the adult bone marrow
In this study we identify strict, lineage-intrinsic requirements 
for continuous Gfi-1b expression in adult erythropoiesis and 
thrombopoiesis. After Gfi-1b loss, no red cells, megakaryo-
cytes, or platelets were produced in the bone marrow, whereas 
progenitors were maintained at increased frequencies. The 
Gfi-1b/ progenitors exclusively gave rise to undifferenti-
ated, abnormally large colonies ex vivo. Yet their identity was 
Gfi-1N1bC mutant (fourth row), the C terminus of Gfi-1b was fused to the N terminus of Gfi-1. (C) Scheme of the Gfi-1b/ pre-MegE rescue. (D) Repre-
sentative cytospin preparations of progenitor colonies on day 12 after lentiviral gene transfer of Gfi-1b/ pre-MegEs with GFP alone (first row), Gfi-1b 
with GFP (second row), Gfi-1 with GFP (third row), Gfi-1bN1C with GFP (fourth row), and Gfi-1N1bC with GFP (fifth row). Colonies were stained with 
MGG (left) and benzidine (middle) and for AchE activity (right). Note the presence of benzidine+ erythrocytes (black arrows) and AchE+ megakaryo-
cytes (white arrows) after transduction of Gfi-1b, Gfi-1, Gfi-1bN1C, and Gfi-1N1bC but not GFP alone. (E) Scheme of the Gfi-1b/ MkP rescue. 
(F–H) Analysis of proplatelet formation from Gfi-1b/ MkPs. (F) Representative phase-contrast micrographs on days 3 (left) and 8 (right) after lentiviral 
gene transfer of GFP alone (first row), Gfi-1b with GFP (second row), Gfi-1 with GFP (third row), Gfi-1bN1C with GFP (fourth row), and Gfi-1N1bC 
with GFP (fifth row). Note the formation of proplatelet-forming megakaryocytes in all conditions but GFP alone. Bars: (D, left) 10 µm; (D, middle and 
right) 100 µm; (F) 50 µm. (G) Quantification of proplatelet formation 8 d after infection of Gfi-1b/ MkPs. Note that the efficiency of Gfi-1b and 
Gfi-1bN1C in giving rise to proplatelet is comparable and significantly higher than that of Gfi-1 or Gfi-1N1bC. Data are shown as means ± SD of  
the number of proplatelet-forming megakaryocytes in three independent experiments (***, P < 0.001; **, P < 0.005; two-tailed Student’s t test).  
(H) Western blot analysis using M2 anti-flag antibody (top) in day 8 megakaryocytic cultures derived from infected Gfi-1b/ MkPs. Expression level 
of -actin (bottom, same blot after stripping) was used as a control for loading.
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disruption in monopotent MkPs (Fig. 8 F). To our knowl-
edge, an arrest at the promegakaryocyte stage is unprecedented. 
Thus, Gfi-1b marks a novel entry point for illuminating this 
important, unexplored stage of thrombopoiesis, when nuclear 
maturation is largely complete and the cytoplasm still immature. 
Very recently, mutations of Gfi-1b have been found in two 
families with platelet-related bleeding disorders (Stevenson 
et al., 2013; Monteferrario et al., 2014), illustrating the high 
clinical relevance of understanding Gfi-1b’s molecular func-
tion in thrombopoiesis.
Gfi-1b is an essential, major player  
in the network of erythroid regulators
In the erythroid lineage, the loss of function phenotype asso-
ciated with Gfi-1b bears striking similarities with findings after 
the disruption of three other critical lineage-restricted regula-
tors, a complete block of red blood cell production which does 
not entirely extinguish the early erythroid program (Fig. 9, 
bottom). In the absence of Klf1, erythroid development was 
arrested only slightly later, after the formation of fully commit-
ted erythroid progenitors (Pilon et al., 2008). Adult disruption 
(Li et al., 2010). However, Nf-e2 loss was associated with a 
later block at the stage of proplatelet formation, and AchE-
positive megakaryocytes were abundantly formed (Lecine et al., 
1998). In contrast, loss of Fog1 resulted in an earlier block with 
an absence of MkPs (Mancini et al., 2012). The stage of the 
requirement of Ldb1 within thrombopoiesis is not fully de-
fined because of its essential role in HSC maintenance (Li et al., 
2011). Similarly, Lmo2 and Gata2 are critical for HSC func-
tion and megakaryopoiesis but have yet to be studied with 
lineage-specific KO systems (Warren et al., 1994; Huang et al., 
2009). Finally, absence of Gata1, Fli-1, Scl1, Tel/Etv6, Runx1, 
Mkl1, Mkl2, and Srf was associated with much less severe 
thrombocytopenia and compatible with the development of 
mature, if abnormal, megakaryocytes (Tijssen and Ghevaert, 
2013). In addition, none of the above regulators exhibited re-
duced mRNA expression in Gfi-1b/ MkPs (Fig. 7 C). How-
ever, it is highly likely that many individual megakaryocytic 
genes are jointly regulated by Gfi-1b and the known lineage-
restricted regulators. Consistent with this notion, our genomic 
analysis revealed that significant numbers of Gata1 or Ldb1 
targets that are bound by Gfi-1b are up-regulated after Gfi-1b 
Figure 7.  Pre-MegEs and MkPs partially 
preserve their molecular program after 
Gfi-1b loss. (A–D) Analysis of gene expression 
in sorted Gfi-1b+/+ and Gfi-1b/ pre-MegEs 
and MkPs. (A) Analysis of megakaryocytic 
lineage–restricted genes (Tpor, thrombopoi-
etin receptor; Fli1; Gp5, platelet glycoprotein V; 
Vwf, Von Willebrand factor). (B) Analysis of  
erythroid lineage–restricted genes (Epor, 
erythropoietin receptor; Klf1, [Eklf]; Ermap, 
erythroid membrane-associated protein).  
(C) Analysis of megakaryocytic transcriptional 
regulators in MkPs (Nfe2, Gata1, Gata2, Fog1, 
Tal1 [Scl], Lmo2, Ldb1, Fli1, Etv6 [Tel], Ikaros, 
Runx1 [Aml1], Mkl1, Mkl2, and Srf). (D) Analy-
sis of erythroid transcriptional regulators in 
pre-MegEs (Klf1 [Eklf], Gata1, Gata2, Fog1 
[Zfpm1], Tal1 [Scl], Lmo2, and Ldb1). mRNA 
expression relative to -actin expression is 
shown as mean ± SD of three independent 
biological replicates (***, P < 0.001; **, P < 0.005; 
*, P < 0.05; two-tailed Student’s t test).JEM Vol. 211, No. 5 
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Figure 8.  Genome-wide analysis of Gfi-1b’s impact on megakaryocytic and erythroid gene expression in progenitors. (A) Affymetrix Mouse 
GeneChip 1.0 ST microarray analysis of control and Gfi-1b/ pre-MegEs (left; gene list in Table S1) and MkPs (right; gene list in Table S2). Shown are 
numbers of genes with 1.5-fold expression changes after Gfi-1b disruption (blue frame: repressed genes; green frames: activated genes). Numbers of 
direct Gfi-1b targets are shown in filled blue and green boxes (peaks defined as 10 kb from transcription start site to 1 kb from gene end, based on 
a published ChIP-seq gene set [Wilson et al., 2010]; see Table S3). (B) GSEA of control and Gfi-1b/ pre-MegEs (left) and MkPs (right) with Gfi-1b–
bound gene set (see Table S3). (C) GSEA of control and Gfi-1b/ pre-MegEs (left) and MkPs (right) with Gfi-1b–bound erythroid gene set (left; 155 Gfi-1b–
bound/533 literature-defined genes [Li et al., 2013]; see Table S3) or Gfi-1b–bound megakaryocytic gene set (right; 31 Gfi-1b–bound/57 literature-defined 
genes [Chen et al., 2007]; see Table S3). (D) Examples of erythroid and megakaryocytic lineage genes that are deregulated after loss of Gfi-1b in pre-
MegEs and MkPs. Asterisks indicate Gfi-1b–bound genes (Table S3). (E) Pie charts for comparison of the ratio of repressed and activated literature-
defined erythroid genes (Li et al., 2013) by Gfi-1b (top left; Table S1), Gata1 (top right; Yu et al., 2009), Klf1 (bottom left; Tallack et al., 2012), and Ldb1 
(bottom right; Li et al., 2013). Dashed lines indicate bound targets. (F) GSEA of control and Gfi-1b/ pre-MegEs with Gfi-1b–bound, regulated 
direct Gata1 targets (top left; 355 Gfi-1b–bound/791 Gata1 targets [Yu et al., 2009]; see Table S3), Gfi-1b–bound regulated Klf1 targets (top right; 
242 Gfi-1b–bound/813 Klf1-regulated genes [Tallack et al., 2012]; see Table S3), and Gfi-1b–bound, regulated direct Ldb1 targets (bottom; 553  
Gfi-1b–bound/1,206 Ldb1 targets [Li et al., 2013]; see Table S3). NESs and nominal p-values are shown for all GSEAs.922 Gfi-1b in adult red cell and platelet generation | Foudi et al.
and the Ldb1-assocated pentameric complex predominantly 
activate gene expression (Soler et al., 2010; Tallack et al., 2012), 
whereas Gata1 activates and represses about half of its targets in 
unbiased genome-wide studies (Yu et al., 2009; Kerenyi and 
Orkin, 2010). The mechanism of Gata1’s repressive activity re-
mains incompletely understood. At some Gata1 target genes, 
repression involves recruitment of the NuRD complex by 
Gata1’s cofactor Fog1, but at other Gata1 targets, Fog and 
NuRD mediate gene activation (Miccio et al., 2010). The pres-
ence of the Ldb1-associated pentameric complex strongly pre-
dicts activation of Gata1 target genes (Tripic et al., 2009;  Yu et al., 
2009). Gfi-1b copurifies with Gata1 in biochemical assays, 
raising the possibility that a physical interaction with Gfi-1b 
confers repressive activity to Gata1 (Rodriguez et al., 2005; 
Yu et al., 2009). Consistent with this notion, we demonstrated 
that a significant number of Gata1 target genes were up-regulated   
in Gfi-1b/ progenitors (Fig. 8 F). However, Gfi-1b’s presence 
only weakly distinguished Gata1-repressed and -activated genes 
(not  depicted).  Moreover,  Gfi-1b  loss  significantly  correlated 
with the increased expression of the target genes it shares with 
Ldb1. Thus, Gfi-1b’s repressive activity is not limited to genes that 
are repressed by Gata1. The emerging picture is that the expres-
sion levels of lineage-restricted genes are determined by the bal-
ance of the activity of several multiprotein complexes organized 
by lineage-restricted transcription factors. Gfi-1b is the hall-
mark component of the first erythroid/megakaryocyte lineage–
restricted complex with predominant repressive activity.
A potential role for Gfi-1b in gene activation might be in-
ferred from our finding that a considerable minority of Gfi-1b–
bound genes exhibit reduced expression after Gfi-1b loss   
(Fig. 8 A). We cannot exclude the possibility that Gfi-1b has 
unrecognized functions in enhancing gene expression. Although 
highly speculative, it is conceivable, for example, that the po-
tential interaction with Gata1 may allow Gfi-1b to indirectly 
recruit factors with a positive impact on gene expression, such 
as Fog1/NuRD or CBP (Blobel et al., 1998; Tripic et al., 2009). 
Alternatively, in light of Gfi-1b’s large target gene spectrum, 
such ostensibly activated genes may be subject to indirect (trans) 
effects overriding the local repressive impact of Gfi-1b. We note 
that to date direct evidence for a role of Gfi-1b in activating 
genes has not been reported. In contrast, in vitro assays, the 
spectrum of molecules interacting with it, and the predomi-
nant impact on gene expression reported here all support its 
function as a transcriptional repressor.
of Gata1 or its cofactor Fog1 was followed by an arrest at the 
same immunophenotypic progenitor stage as Gfi-1b loss (Fig. 9; 
Mancini et al., 2012). However, we demonstrate that Gfi-1b 
is dispensable for the expression of these three regulators. Like-
wise, Gfi-1b was not required for the expression of any of the 
major components of the pentameric complexes (Ldb1, Scl/
Tal1, Lmo2, E2A, and Gata1) that associate with Gata1 to acti-
vate a subset of its target genes (Fig. 8 F and not depicted; 
Soler et al., 2010; Li et al., 2013). In agreement with the pre-
served or increased expression of these erythroid regulators, 
GSEA demonstrated significant up-regulation of target genes 
of Ldb1, Gata1, and Klf1 after Gfi-1b loss (Fig. 8 F and not 
depicted). By superimposing previously generated datasets (Yu 
et al., 2009; Wilson et al., 2010; Li et al., 2013), we found that 
Gfi-1b binds a remarkably high proportion of the direct tar-
gets of Gata1 and Ldb1 (44.8% and 45.8%, respectively). As 
transcription factor binding dynamically changes during eryth-
roid differentiation (May et al., 2013), our indirect compari-
son, using data from cell lines that are not entirely matched in 
their differentiation stage, likely underestimates the true num-
ber of shared occupied genes. Yet GSEAs revealed that loss of 
Gfi-1b was associated with a significant increase in up-regulated 
genes occupied together with Gata1 or Ldb1 (Fig. 8 F). We 
speculate that the combined abnormal expression of a large 
number of lineage-associated genes in Gfi-1b’s absence pre-
vents the execution of the complex programs required for the 
progression of erythroid maturation. The similarities in loss 
of function phenotypes associated with Gfi-1b, Gata1, and 
other major erythroid regulators are likely related to the large 
overlap in their target genes. Regardless, our data provide the 
first evidence for a broad, direct role of Gfi-1b in the regula-
tion of a wide spectrum of erythroid genes.
Gfi-1b as lineage-restricted master repressor of transcription
Previous studies have established that Gfi-1b functions as a tran-
scriptional repressor (Zweidler-Mckay et al., 1996; Tong et al., 
1998). It physically interacts with and locally recruits chromatin-
modifying enzymes that generate histone modifications associ-
ated with reduced transcription, including Lsd1, G9a, Hdac1, 
and Hdac2 (McGhee et al., 2003; Duan et al., 2005;  Vassen et al., 
2006; Saleque et al., 2007). Consistent with these insights into 
its molecular role, the majority of genes bound by Gfi-1b ex-
hibited increased expression after its disruption in the eryth-
roid and megakaryocytic lineages (Fig. 8 A). In contrast, Klf1 
Figure 9.  Schematic representation of 
Gfi-1b’s role in normal erythropoiesis 
and thrombopoiesis. The top illustrates the 
position of the block that follows Gfi-1b 
disruption in megakaryocytic lineage matu-
ration (black bar). The bottom shows the 
position of the erythroid lineage block after 
Gfi-1b loss (red bar). Gray arrows indicate 
the positions of blocks that follow loss of 
other lineage regulators.JEM Vol. 211, No. 5 
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Gfi-1b alleles (age 4–8 wk) were subjected to daily doxycycline injections 
(D9891; Sigma-Aldrich; 10 µg/g mouse weight; diluted 1 mg/ml in PBS) and 
doxycycline-supplemented drinking water (2 mg/ml doxycycline, 10 mg/ml 
sucrose) for up to 4 wk. For Mx-Cre–mediated gene recombination, a total 
of three intraperitoneal injections (at 8.5 µg/g mouse bodyweight) of pIpC 
(GE Healthcare) were administered every other day.
Bone marrow transplantation. Competitive bone marrow transplanta-
tion was performed by intravenous injection of 4 × 106 total bone marrow 
cells from control or conditional Gfi-1b KO mice (CD45.2 positive) to-
gether with 2 × 106 competitor bone marrow cells (B6.SJL, CD45.1 posi-
tive) into B6.SJL recipients that had received 12 Gy of radiation as a split 
dose as described previously (Hock et al., 2004b).
Complete blood counts. Analysis was performed using a VetScan MS5 
hematology system (Abaxis).
Flow cytometry. Antibody conjugates were purchased from BD or eBio-
science, unless otherwise indicated. Data were collected using either a FACS-
Aria II cell sorter or an LSR II (BD) and analyzed with FlowJo (Tree Star). 
Dead cells were excluded using 1 µg/ml propidium iodide; doublets were 
excluded using forward and side scatter width parameters. Antibodies used 
for bone marrow pre-MegE and MkPs (adapted from Pronk et al. [2007]) are   
as follows: lineage markers (CD4 [RM4-5], CD8 [53-6], CD3e [145-2C11], 
B220 [RA3-6B2], Gr-1 [RB6-8C5], CD127 [IL-7Ra, A7R34], and Ter119 
[all PE-Cy5]), CD117 (c-Kit, 2B8, APC–eFluor 780), Sca-1 (D7, PE-Cy7), 
FcgRII/III (2.4G2, PE), CD150 (Slamf1, TC15-12F12.2, APC; BioLegend), 
CD41 (GPIIb, MWReg30, FITC), and CD105 (Endoglin, MJ7/18, eFluor 
450). Antibodies used for bone marrow erythroid precursors (stain performed 
without red blood cell lysis) were rat anti–mouse CD71 (TFRC, RI7 217.1.4, 
PE) and rat anti–mouse Ter-119 (Ly76, TER-119, FITC). Antibodies used 
for bone marrow megakaryocytic precursors were rat anti–mouse CD41 
(GPIIb, MWReg30, eFluor 450) and rat anti–mouse CD42b (GPIbalpha, 
Xia.G5, PE; emfret ANALYTICS). For megakaryocyte ploidy analysis, bone 
marrow cells were fixed in ice-cold 70% ethanol overnight and stained with 
1 µg/ml DAPI (D1306; Invitrogen) for 30 min at room temperature in 
DAPI/Triton X-100 staining solution (0.1% Triton X-100 in PBS and 1 µg/ml 
DAPI) and protected from direct light exposure. Thereafter, cells were col-
lected on an Aria II flow cytometer (BD) and analyzed using Kaluza analysis 
software (Beckman Coulter).
Quantitative imaging flow cytometry. To assess the morphology and 
size of CD41+CD42+ megakaryocytes in vivo in transplanted animals, we 
used an Amnis ImageStream MkII imaging flow cytometer (EMD Millipore), 
which combines high-resolution microscopy and flow cytometry. In brief, 
bone marrow cells from Gfi-1b+/ and Gfi-1b/ posttransplant recipients 
(7 wk after doxycycline) were immunostained for megakaryocytes as described 
above, together with a rat anti-CD45.2 FITC antibody (to distinguish con-
ditional KO from competitor cells) and DRAQ5 (to label DNA). Data were 
collected on the Amnis imaging flow cytometer (105 events/file, 13 files/
genotype were merged) and analyzed using IDEAS software (version 6.0). 
Cellular debris was excluded by gating on DRAQ5-positive events first, fol-
lowed by CD41-positive/CD42-positive events. After excluding false-
positive cellular aggregates, single CD45.2-positive and CD45.2-negative 
CD41+CD42+ cells were tagged, and their morphology was assessed. Tagged 
cells were then back-gated on the area of CD41 versus the area of CD42 bi-
variate plots for size quantification. Data were collected using a 40× objective 
(66 mm/s, 10-µm core diameter) and five lasers (405 nm, 20 mW; 488 nm, 
50 mW; 561 nm, 100 mW; 642 nm, 150 mW; 785 nm, 1.56 mW for SSC). 
Single color controls were acquired without brightfield or side scatter, and 
spectral compensation was performed after acquisition.
Generation of expression vectors and mutagenesis. Gfi-1b and Gfi-1   
full-length cDNAs were amplified by PCR and modified to incorporate 
a C-terminal FLAG tag using the following primers: Gfi-1b sense (NotI),   
Further investigations are needed to fully define Gfi-1b’s 
interplay with the other, more extensively studied lineage-
restricted regulators in establishing and fine-tuning the ex-
pression levels of many megakaryocytic and erythroid genes. 
A complete understanding of the transcriptional programs of 
these vitally important lineages will require a detailed study of 
the dynamism of the transcription factor occupancy and activi-
ties as differentiation proceeds, and it will need to capture the 
influence of long-range interactions.
MATERIALS AND METHODS
Mice. Mice were housed at Massachusetts General Hospital in a specific patho-
gen–free environment. All animal experiments were performed after approval 
and according to the guidelines and supervision of the Massachusetts General 
Hospital Subcommittee on Research Animal Care. B6.SJL (ref: 002014) re-
cipient mice and Mx-Cre mice were purchased from The Jackson Laboratory. 
The R26-M2rtTA::TetOP-Cre mice (TetO-Cre) will be available from The 
Jackson Laboratory (JAX Stock# 021025). All animals were genotyped by 
Southern blot or by PCR using the HotStarTaq DNA polymerase (QIAGEN).
Construction of the conditional Gfi-1b targeting vector. A 9.8-kb 
Gfi-1b genomic BsaB1–Sal1 fragment including exons 2–6 (Saleque et al., 
2002) was subcloned into pBluescript II KS (pBS) vector. A selectable neo-
mycin cassette containing the 5 LoxP site and flanked by two FRT sites (Liu 
et al., 2003) was inserted into the Nde1 site of pBS–Gfi-1b. To introduce 
the 3 LoxP site, an adapter containing the 5 Hind3–EcoRV site (primers: 
sense,  5-AAGCTTGATATCTAATATAACTTCGTATAATGTATGC-
TATACGAAGTTATTAG-3; and antisense, 5-CTAATAACTTCG-
TATAGCATACATTATACGAAGTTATATTAGATATCAAGCTT-3) 
was inserted into the Swa1 site (between exons 5 and 6 of pBS–Gfi-1b). 
After sequencing, the vector was linearized with NotI for subsequent elec-
troporation in embryonic stem (ES) cells (see below).
Generation  of  Gfi-1b–targeted  ES  cells  and  mutant  mice. V6.5 
(129SvJae × C57BL/6; Eggan et al., 2001) ES cells were cultured on irradi-
ated MEFs generated from DR4 embryos (Tucker et al., 1997) as described 
previously (Qin et al., 2010). Targeting vectors were introduced into ES cells 
by electroporation and selected with 400 µg/ml G418. Correctly targeted 
neomycin-positive ES cells were identified by Southern blot analysis (Fig. 1, 
A–C). Thereafter, the neomycin resistance cassette was removed by electropo-
ration of the Flpe-expressing pCAGGS vector (Buchholz et al., 1998; Rodríguez 
et al., 2000), and subsequent puromycin (1 µg/ml) selection (Fig. 1, A and D) 
leading to the generation of heterozygous Gfi-1bwt/floxed (Gfi-1bwt/fl) ES cells. 
To create the Gfi-1b–null (Gfi-1bwt/ko) allele (Fig. 1 A, bottom), a plasmid 
expressing a GFP-Cre fusion protein (pBS500) was introduced by electro-
poration in targeted neomycin-positive ES cells (Gagneten et al., 1997). After 
48 h, GFP-Cre–positive cells were FACS sorted, expanded in culture, and con-
firmed by Southern blot analysis (Fig. 1 E). Selected Gfi-1bwt/flox and Gfi-1bwt/ko 
ES cell clones were karyotyped, injected into C57BL/6 blastocysts, and trans-
ferred into pseudopregnant foster mothers to generate chimeras. Male chimeras 
were bred to C57BL/6 female mice for germ line transmission. Homozygous 
conditional Gfi-1b KO mice (Gfi-1bfl/fl) were generated and had normal 
viability, fertility, and blood parameters.
Generation  of  tetracycline-inducible  Cre  expression  transgenic 
mice. Tetracycline-inducible Cre expression (M2-rtTA; TetO-Cre) trans-
genic animals (Fig. 2) were generated from ES cells after targeting the Cre 
recombinase  cDNA  (pTurbo-Cre;  GenBank  accession  no.  AF334827.1) 
downstream of the collagen 1A1 locus under the control of a tetracycline-
dependent CMV minimal promoter as previously described previously (Beard 
et al., 2006; Foudi et al., 2009).
Cre-mediated recombination in vivo. For TetO-Cre–mediated gene 
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for 8 min at room temperature (9 vol of 0.2% o-Dianisidine [D9143] in 10% 
glacial acetic acid [Sigma-Aldrich] and 1 vol of 30% H2O2 [H325; Thermo 
Fisher Scientific]).Thereafter, samples were cytocentrifuged, counterstained 
with May-Grünwald solution for 10 s, and washed in water. For AchE stain, 
samples were cytocentrifuged and stained using the AchE rapid staining kit 
(MBL International) according to the manufacturer’s guidelines. Slides were 
coverslipped using Permount and analyzed by brightfield microscopy.
RNA extraction and quantitative RT-PCR. Bone marrow pre-MegE 
and MkPs from a cohort of n = 3 Gfi-1b+/+ and n = 3 Gfi-1b/ (15–19 d 
after doxycycline, number of cells ranging from 2 × 104 to 5 × 104 per sam-
ple) were double FACS sorted to achieve >99% purity by FACS and sus-
pended in 500 µl TRIzol (Invitrogen). Total RNA was isolated according to 
the manufacturer’s recommendations (Invitrogen) and purified using the 
RNeasy Micro kit (QIAGEN). All RNA samples had their integrity checked 
using an RNA 6000 Pico kit on a 2100 Bioanalyzer (Agilent Technologies) 
and RIN numbers ranged from 8 to 10. RT was performed using iScript 
cDNA synthesis kit (Bio-Rad Laboratories). Quantitative RT-PCR was per-
formed using either Brilliant II SYBR green QPCR master mix (Agilent 
Technologies) or SYBR green I master (Roche) and run on a Stratagene 
Mx3005P (Agilent Technologies) or LightCycler 480 (Roche), respectively. 
All reactions were performed in triplicate, and data were generated using the 
comparative Ct method using actin-b as reference gene (2Ct; Ct = 
Ctsample  Ctreference). Primers were designed to span one intron on the 
corresponding genomic DNA sequence (Tables S4 and S5).
Microarrays and GSEA. Microarrays were performed at Partners Center 
for Personalized Medicine (Boston, MA). In brief, 2 ng total RNA (RIN > 8) 
from control and Gfi-1b/ pre-MegEs and MkPs were amplified with an 
Ovation Pico WTA system (NuGEN), reverse transcribed to cDNA with the 
WT-Ovation Exon Module, and prepared for fragmentation and labeling 
using the Encore Biotin Module (NuGEN) according to the manufacturer’s 
protocol. Amplified cDNA were biotinylated, fragmented, and hybridized to 
Mouse GeneChip 1.0 ST arrays (Affymetrix). The stained arrays were scanned 
at 532 nm using a GeneChip Scanner 3000 (Affymetrix). The GeneSifter 
microarray analysis server (Geospiza) was used to generate lists of deregulated 
genes with >1.5-fold change in expression (Tables S1 and S2). To test whether 
defined sets of genes show statistically significant and concordant differ-
ences between control and Gfi-1b/ pre-MegEs and between control and 
Gfi-1b/ MkPs, we performed GSEA (Mootha et al., 2003; Subramanian 
et al., 2005) using previously published datasets (Table S3). Each GSEA was run 
using “Gene Sets” as permutation type with “1,000 permutations.” A normal-
ized  enrichment  score  (NES)  is  determined  and  reflects  whether  genes 
within a defined dataset are either randomly distributed (NES value close to 0) 
or primarily found at the top (NES value > 1) or bottom (NES value < 1) 
of the ranked gene list. GSEA also provides a false discovery rate correspond-
ing to the probability (q-value) of each NES to be a false positive.
Statistical analysis. Statistical significance was determined by two-tailed 
Student’s t test. Kaplan–Meyer survival curves were generated using Prism 
software (version 6; GraphPad Software). Statistical significance of the sur-
vival distributions was determined by Log-rank test (Mantel-Cox).
Online supplemental material. Tables S1 and S2, included as separate 
Excel files, show lists of deregulated genes after Gfi-1b loss in pre-MegEs and 
MkPs, respectively. Table S3, included as a separate Excel file, shows gene sets 
used in genomics analyses. Tables S4 and S5 list primers used for quantitative 
RT-PCR and genotyping PCR, respectively. Online supplemental material 
is available at http://www.jem.org/cgi/content/full/jem.20131065/DC1.
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5-GCTAGCGGCCGCGCCGCCACCATGCCACGGTCCTTTCTAGTG-3; 
and  antisense  (BamHI),  5-AATTGGATCCTCACTTGTCGTCAT-
CGTCTTTGTAGTCCTTGAGATTGTGTTGACTCTC-3;  and  Gfi-1   
sense (NotI), 5-GCTAGCGGCCGCGCCGCCACCATGCCGCGCTC-
ATTCCTGGTC-3; and antisense (BamHI), 5-AATTGGATCCTCACTT-
GTCGTCATCGTCTTTGTAGTCTTTGAGTCCATGCTGAGTCTC-3. 
Two DNA-binding swap mutants were generated by PCR amplification, 
followed by directional ligation of Gfi-1b N terminus to Gfi-1 C terminus   
(Gfi-1bN1C) or by ligation of Gfi-1 N terminus to Gfi-1b C terminus   
(Gfi-1N1bC). Primers were as follows: for Gfi-1b N terminus sense (NotI), 
5-GCTAGCGGCCGCGCCGCCACCATGCCACGGTCCTTTCTAGTG-3; 
and antisense, 5-AGTGTCCATGCCTGGAGAGTA-3; for Gfi-1b C termi-
nus sense, 5-TACCACTGTGTCAAGTGCAAC-3; and antisense (BamHI),   
5-AATTGGATCCTCACTTGTCGTCATCGTCTTTGTAGTCCTTGA-
GATTGTGTTGACTCTC-3; for Gfi-1 N terminus sense (NotI), 5-GCT-
AGCGGCCGCGCCGCCACCATGCCGCGCTCATTCCTGGTC-3; 
and antisense, 5-GGAGCCGCCGCCCAGCAGCAG-3; and for Gfi-1 C ter-
minus sense, 5-TACAAATGCATCAAATGCAGC-3. DNA fragments were 
then cloned into the NotI–BamHI site of Phage2 lentivirus (Sommer et al., 
2009) directly upstream of an Ires-GFP. All constructs were sequenced before 
generating vectors.
Lentiviral supernatant production and infection. Lentiviral superna-
tants were prepared using 293T packaging cells as previously described (Qin 
et al., 2012). Aliquots of concentrated lentiviral supernatants were stored at 
80°C until the day of infection. Sorted Gfi-1b/ pre-MegEs and MkPs 
were suspended in DMEM, 10% FBS, and 1% penicillin-streptomycin con-
taining 50 ng/ml SCF, 10 ng/ml IL-3, and 20 ng/ml TPO. Cells (105 to   
5 × 105 in 500 µl) were incubated with 50 µl (diluted in 500 µl culture me-
dium) concentrated lentiviral supernatant supplemented with 8 µg/ml poly-
brene (H9268, hexadimethrine bromide; Sigma-Aldrich) and centrifuged at 
2,500 RPMs for 90 min at room temperature. Cells were washed in com-
plete DMEM before being put in culture. Infected pre-MegEs were seeded 
at 103 cells/ml in semisolid medium for CFU-C assay, as described below. 
Infected MkPs were plated in megakaryocyte differentiation condition as 
described below.
Megakaryocytic differentiation and proplatelet formation. Infected 
Gfi-1b/ MkPs were suspended in DMEM, 10% FBS, and 1% penicillin-
streptomycin containing 25 ng/ml SCF and 10 ng/ml TPO and seeded onto 
fibronectin-coated (40 µg/ml; EMD Millipore) wells. Cells were cultured at 
37°C in 5% CO2 for 8 d and monitored with a fluorescence microscope 
(DMI4000B; Leica) for the emergence of GFP-positive megakaryocytes and 
proplatelet-forming megakaryocytes.
CFU-C  assays  from  pre-MegEs  and  MkPs. Sorted pre-MegEs and 
MkPs were seeded at 500 cells/dish of 35-mm colony dishes (STEMCELL 
Technologies) in Methocult M3234 (STEMCELL Technologies) supple-
mented with 25 ng/ml SCF, 10 ng/ml IL-3, 20 ng/ml IL-11, 10 ng/ml 
GM-CSF, 3 U/ml Epo, and 10 ng/ml Tpo. Colonies were scored between 
7 and 10 d using an inverted microscope (DMI 4000B; Leica).
Cytology and histochemistry. For whole bone marrow sections, tissues 
were fixed in Bouin’s solution and embedded in paraffin. Embedded bone 
marrow blocks were sliced and stained with H&E for conventional morpho-
logical assessment. For cytocentrifugation preparations, bone marrow cells were 
subjected to red blood lysis in ACK buffer (0.15 mM NH4Cl, 1 mM KHCO3, 
and 0.1 mM Na2EDTA). Between 2 × 105 and 5 × 105 cells were suspended 
in 100 µl PBS, loaded onto disposable Cytofunnel chambers and spun down 
for 4 min at 400 RPM using a CytoSpin III cytocentrifuge (Shandon). For 
MGG stain, cytocentrifuged samples were stained in May-Grünwald solution 
(MG500; Sigma-Aldrich) for 2 min and in Giemsa (GS500, 5% solution in 
water; Sigma-Aldrich) for 12 min, followed by two washes in distilled water 
for 30 s. For benzidine stain, hematopoietic cells (2 × 105 to 5 × 105) were sus-
pended in 200 µl PBS and mixed with 20 µl O-dianisidine/H2O2 mixture JEM Vol. 211, No. 5 
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